Coronary artery spasm constitutes a significant portion of patients with acute coronary syndrome. Calcium channel blocker and nitrate are the mainstream therapies, but some patients are medically refractory to these medical therapies. In addition, the best treatment strategies for these patients remain uncertain, and medically refractory left main coronary artery spasm is a clinical dilemma. The present case report presents a 43-year-old man with such condition, which was successfully treated by percutaneous coronary intervention with implantation of a drug-eluting stent. He remained symptom-free for three years, without restenosis on follow-up angiography.
<Learning objective: Refractory left main coronary artery spasm is a clinical challenge. In selective cases, percutaneous coronary intervention with drug-eluting stent implantation is a feasible treatment choice.Refractory left main coronary artery spasm is a clinical challenge. In selective cases, percutaneous coronary intervention with drug-eluting stent implantation is a feasible treatment choice.>
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Cardiology Cases
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- 3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up.J Am Coll Cardiol. 2011; 57: 147-152
- Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013).Circ J. 2014; 78: 2779-2801
- Treatment of spontaneous left main coronary artery spasm with a drug-eluting stent.Acta Cardiol Sin. 2009; 25: 43-46
- Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis.J Am Coll Cardiol. 2002; 39: 1120-1126
- Refractory spasm of coronary arteries and grafted conduits after isolated coronary artery bypass surgery.Ann Thorac Surg. 2012; 93: 545-551
- Differences and interactions between risk factors for coronary spasm and atherosclerosis—Smoking, aging, inflammation, and blood pressure.Intern Med. 2014; 53: 2663-2670
- Beneficial effects of long-acting nifedipine on coronary vasomotion abnormalities after drug-eluting stent implantation: the NOVEL study.Eur Heart J. 2016; 37: 2713-2721
- Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association.Eur Heart J. 2013; 34: 258-267
- Acetylcholine-provoked coronary spasm at site of significant organic stenosis predicts poor prognosis in patients with coronary vasospastic angina.J Am Coll Cardiol. 2015; 66: 1105-1115
Published online: December 08, 2021
Accepted: November 17, 2021
Received in revised form: November 8, 2021
Received: September 25, 2021
© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.